Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Effectiveness of Remotely Monitored Blood Alcohol Concentration Device as Treatment Modality

NCT04380116 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT04380116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04380116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Effectiveness of Remotely Monitored Blood Alcohol Concentration Device as Treatment Modality
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
June 29, 2020
Completion date
May 1, 2022
Enrollment
96 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder